EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
Bachchu Lal(Kennedy Krieger Institute), John Laterra(Kennedy Krieger Institute)
Cited by 65
Related Papers
Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications
|Signal Transduction and Targeted Therapy|2022|103
Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
|Molecular Cancer Research|2008|92
Cyr61 Mediates Hepatocyte Growth Factor–Dependent Tumor Cell Growth, Migration, and Akt Activation
|Cancer Research|2010|47
Ribotoxic Stress Sensitizes Glioblastoma Cells to Death Receptor–Induced Apoptosis: Requirements for c-Jun NH2-Terminal Kinase and Bim
|Molecular Cancer Research|2007|41